|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0022877,
umls-concept:C0034378,
umls-concept:C0205101,
umls-concept:C0332466,
umls-concept:C0441889,
umls-concept:C0442711,
umls-concept:C0442726,
umls-concept:C0679823,
umls-concept:C0814037,
umls-concept:C1511790,
umls-concept:C1519595,
umls-concept:C1826672,
umls-concept:C2003941,
umls-concept:C2728259,
umls-concept:C2827666
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2001-6-21
|
|
pubmed:abstractText |
The detection of PML-RAR by reverse transcription (RT) polymerase chain reaction (PCR) in acute promyelocytic leukemia (APL) patients who are in hematologic remission influences therapeutic decision making in several trials. In the light of this, the Spanish group has recently designed an external quality assessment program (EQAP) of RT-PCR detection of PML-RAR, which includes a study of sensitivity of the participating laboratories.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0390-6078
|
|
pubmed:author |
pubmed-author:BarragánEE,
pubmed-author:BoluferPP,
pubmed-author:BornsteinRR,
pubmed-author:CabelliVV,
pubmed-author:CassinatBB,
pubmed-author:ChomienneCC,
pubmed-author:ColomerDD,
pubmed-author:DelgadoM DMD,
pubmed-author:DiverioDD,
pubmed-author:García-MarcoJ AJA,
pubmed-author:GondaJ NJN,
pubmed-author:GonzalezMM,
pubmed-author:GrimwadeDD,
pubmed-author:JansenJJ,
pubmed-author:Lo CocoFF,
pubmed-author:MartinezBB,
pubmed-author:MaruganII,
pubmed-author:RománJJ,
pubmed-author:SanzM AMA,
pubmed-author:VillegasAA,
pubmed-author:VizmanosJ LJL,
pubmed-author:de BlasJ MJM
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
86
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
570-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11418365-Humans,
pubmed-meshheading:11418365-Laboratories,
pubmed-meshheading:11418365-Neoplasm Proteins,
pubmed-meshheading:11418365-Observer Variation,
pubmed-meshheading:11418365-Oncogene Proteins, Fusion,
pubmed-meshheading:11418365-Quality Control,
pubmed-meshheading:11418365-RNA, Messenger,
pubmed-meshheading:11418365-Reproducibility of Results,
pubmed-meshheading:11418365-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:11418365-Tumor Cells, Cultured
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols.
|
|
pubmed:affiliation |
Laboratory of Molecular Biology, Department of Clinical Pathology, Hospital Universitario La Fe, Valencia, Spain. bolufer_pas@gva.es
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
